HHLR ADVISORS, LTD.

CIK 1762304 · last filed 2024-02-01

HHLR ADVISORS, LTD. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2022. Across all open-market trades the lifetime net is −$1.17B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $130.1M across reported positions. The firm reports its address in Grand Cayman, E9. 15 SEC filings were submitted jointly with BeiGene, Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$130.06M

Companies

2

Total Filings

6

Lifetime Open-Market Net

-$1.17B

Filer Profile

Reported Address
OFFICE #122, WINDWARD 3 BUILDING
REGATTA OFFICE PARK, WEST BAY ROAD
GRAND CAYMAN, E9 KY1-9006
Phone
(345) 749-8643
State of Incorporation
Cayman Islands
Formerly Known As
Hillhouse Capital Advisors, Ltd. (2019–2021)
HILLHOUSE CAPITAL ADVISORS, LTD. (2019–2021)
Related Filers
BeiGene, Ltd. — 15 joint filings, latest 2025-05-13
HILLHOUSE INVESTMENT MANAGEMENT, LTD. — 7 joint filings, latest 2026-02-03
EastBridge Investment Group Corp — 6 joint filings, latest 2020-06-24
Beam Therapeutics Inc. — 2 joint filings, latest 2022-02-14
Enstar Group LTD — 2 joint filings, latest 2021-07-19
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVBP 10%+ Owner 4,484,672 $29.00 $130.06M $20.00M 1 2024-02-01
BeOne Medicines Ltd. (BGNE) Delisted 10%+ Owner 145,055,181 $184.71 $26.79B -$1.19B 2 2023-06-12

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-03-03 Notice (144) −2,480,000 -$674.06M EDGAR
2024-12-02 Notice (144) −1,372,500 -$295.09M EDGAR
2024-02-01 AVBP Mixed +8,969,344 $20.00M EDGAR
2023-06-12 BeOne Medicines Ltd. (BGNE) Delisted Sell (S) −5,913,378 -$1.19B EDGAR
2023-06-09 Notice (144) −295,409 -$66.29M EDGAR
2022-08-24 BeOne Medicines Ltd. (BGNE) Delisted Other (J) +15,600 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.